Koberle, B; Ditz, C; Kausch, I et al.
Metastases of squamous cell carcinoma of the head and neck show increased levels of nucleotide excision repair protein XPF in vivo that correlate with increased chemoresistance ex vivoINTERNATIONAL JOURNAL OF ONCOLOGY. Bd. 36. H. 5. 2010 S. 1277-1284
Jacob, R; Shafiei, N; Nagel, G et al.
MGMT Activity in Mucosal Epithelium and Squamous Cell Carcinoma of the Head and NeckANTICANCER RESEARCH. Bd. 30. H. 7. 2010 S. 2561-2566
Cristmann, M; Nagel, G; Horn, S et al.
MGMT activity, promoter methylation and immunohistochemistry of pre-treatment and recurrent malignant gliomasONKOLOGIE. Bd. 33. 2010 S. 6-6
Christmann, M; Nagel, G; Horn, S et al.
MGMT activity, promoter methylation and immunohistochemistry of pretreatment and recurrent malignant gliomas: a comparative study on astrocytoma and glioblastomaINTERNATIONAL JOURNAL OF CANCER. Bd. 127. H. 9. 2010 S. 2106-2118
Eich, M; Roos, WP; Dianov, GL et al.
Nijmegen Breakage Syndrome Protein (NBN) Causes Resistance to Methylating Anticancer Drugs Such as TemozolomideMOLECULAR PHARMACOLOGY. Bd. 78. H. 5. 2010 S. 943-951
Hoehme, S; Brulport, M; Bauer, A et al.
Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regenerationPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. Bd. 107. H. 23. 2010 S. 10371-10376
Quiros, S; Roos, WP; Kaina, B
Processing of O-6-methylguanine into DNA double-strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cyclesCELL CYCLE. Bd. 9. H. 1. 2010 S. 168-178
Jost, E; Roos, WP; Kaina, B et al.
Response of pancreatic cancer cells treated with interferon-alpha or beta and co-exposed to ionising radiationINTERNATIONAL JOURNAL OF RADIATION BIOLOGY. Bd. 86. H. 9. 2010 S. 732-741
Dietrich, C; Weiss, C; Bockamp, E et al.
Stem cells in chemical carcinogenesisArch Toxicol. Bd. 84. 2010 S. 245-51
Kaina, B; Margison, GP; Christmann, M
Targeting O (6)-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapyCELLULAR AND MOLECULAR LIFE SCIENCES. Bd. 67. H. 21. 2010 S. 3663-3681